Economic and Health Value of Delaying Atrial Fibrillation Progression Using Radiofrequency Catheter Ablation.
Adam E BermanMina KabiriTom WeiThibaut GalvainQun ShaKarl-Heinz KuckPublished in: Circulation. Arrhythmia and electrophysiology (2023)
RFCA is a dominant (less costly and more effective) treatment strategy for patients with AF, especially those with early AF for whom RFCA could delay progression to advanced AF. Increased utilization of RFCA-particularly among patients earlier in their disease progression-may provide clinical and economic benefits.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- left atrial appendage
- oral anticoagulants
- direct oral anticoagulants
- heart failure
- healthcare
- public health
- percutaneous coronary intervention
- life cycle
- coronary artery disease
- combination therapy
- risk assessment
- acute coronary syndrome
- health promotion
- venous thromboembolism